Compare Heron Therapeutics Inc (HRTX) vs Oklo Inc (OKLO) Price & Performance

Heron Therapeutics IncTrade

Oklo IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Oklo Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Oklo Inc trades at $47.53 (market cap $8.74B). The key difference: Oklo Inc is far larger — about 142.2× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.

	HRTX	OKLO
Market Cap	$61.47M	$8.74B
Sector	Health	Technology
52-Week High	$1.49	$174.14
52-Week Low	$0.32	$36.84
Enterprise Value	$168.21M	$6.28B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

OKLO

NuScale Power shares fall 32% YTD amid revenue drop and dilution, awaiting key contracts to rebound.24/7 Wall Street · 21 hours agoBearish Oklo posts first revenue with reactor milestone; AST SpaceMobile reports higher revenue but heavy launch loss.24/7 Wall Street · 1 day agoNeutral Oklo posts $1.2M Q2 revenue with 14% stock rise, but core tech validation and cost clarity remain uncertain.Seeking Alpha · 4 days agoNeutral View details →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

About Oklo Inc

Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.